News
6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts say lenacapavir is easier to administer, and each dose lasts longer compared to other medications.
This twice-a-year shot to prevent HIV could stop transmission — if people can get it
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s unclear how many in the U.S. and abroad will get access to the powerful new option.
WDAM on MSN38m
FDA approves twice-yearly injectable for HIV prevention; local agency weighs in on impact in the Pine BeltThe medical community has reached another milestone that could put an end to the decades-long HIV epidemic. The Food & Drug ...
Audacy on MSN1h
There's a new, highly effective HIV drug on the marketA revolutionary new preventative medicine that protects against the HIV virus has just been approved by the U.S. Food and ...
The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
HIV and global health activists say the deployment of Gilead’s twice-a-year HIV prevention shot is the world’s best chance to ...
The recent FDA approval of lenacapavir is encouraging in its promise of long-term HIV prevention but might not be available for the vast majority of people in the US.
US approves breakthrough HIV jab – but aid cuts mean it may not get to millions in need - FDA approval paves the way for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback